Imidazopyridine compounds as 5-HT4 receptor agonists
US7012080B2 · kind B2 · utility
2Cited by
8References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2003 |
| Grant date | Mar 14, 2006 |
| Priority date | — |
| Expiry date | Sep 24, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a compound of the formula (I): or a pharmaceutically acceptable salt thereof, wherein These compounds have 5-HT4 receptor binding activity, and thus are useful for the treatment of gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome or the like in mammalian, especially humans. This invention also provides a pharmaceutical composition comprising the above compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.